课题基金 / 基金详情

Algebraic group techniques for finite(ly presented) groups

Algebraic group techniques for finite(ly presented) groups
有限(已知)群的代数群技术
批准号:
123863751
负责人:
Professor Dr. Wilhelm Plesken
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2009
资助国家:
德国
项目状态:
已结题
起止时间:
2008-12-31 至 2011-12-31

项目摘要

项目成果

Professor Dr. Wilhelm Plesken的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.) In the first part of the project we discovered that finite matrix groups G that are defined, as algebraic groups, over the rational field can be studied via modules over a twisted group ring constructed from the field and the semidirect product of G with the Galois group. Motivated by the fact that it is possible to define characters for those twisted group rings, it remains to study which parts of the classical character theory can be adapted. The theory of Schur indices, especially the theorem of Brauer-Witt, will be in the center of interest.2.) In the second part of the project, the efficient methods to compute the epimorphisms of a finitely presented group onto all finite groups of type L2 have been extended to types L3 and U3. The theoretical insights gained from this are to be developed into a general character theory, which can be applied for instance to determine the Aschbacher class of a matrix group over a finite field. Both, finite group presentations and finitely generated matrix groups over rings of algebraic integers, are to be investigated by the developed methods. E.g., results by Lubotzky on subgroups of SL(n, Z) are to be made constructive.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elimination and Counting via Thomas Decomposition
国内基金
海外基金
一类特殊Abelian群的子群计数问题
  • 批准号:
    12301006
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    隋延坤
  • 依托单位:
分泌蛋白IGFBP2在儿童Group3/Group4型髓母细胞瘤恶性进展中的作用与机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    夏明杨
  • 依托单位:
大兴安岭火山湖Group I长链烯酮冷季节温标研究与过去2000年温度定量重建
  • 批准号:
    42073070
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2020
  • 负责人:
    姚远
  • 依托单位:
TOX3-WDR5信号轴靶向ABCG2促进结肠癌细胞干性维持及化疗和靶向治疗耐药的功能、分子机制和临床意义
  • 批准号:
    82072711
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    郭微
  • 依托单位: